Viewing data from:

PHENTERMINE HYDROCHLORIDE

ANDA

PHENTERMINE HYDROCHLORIDE | A205019 | NUVO PHARMACEUTICAL INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.1220

per ea

Lowest NADAC/Unit

$0.1004

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
11534017601PHENTERMINE 30 MG CAPSULE	$0.1220	EA	Generic	—	2026-06-17
11534017603PHENTERMINE 30 MG CAPSULE	$0.1220	EA	Generic	—	2026-06-17
11534015701PHENTERMINE 15 MG CAPSULE	$0.1004	EA	Generic	—	2026-06-17
11534015703PHENTERMINE 15 MG CAPSULE	$0.1004	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain6 active DMFs4 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED USA LLCPHENTERMINE HYDROCHLORIDE USP

DMF 34321979

OLON SPAPHENTERMINE HYDROCHLORIDE

DMF 152892001

CHEMISCHE FABRIK BERG GMBHPHENTERMINE HYDROCHLORIDE USP

DMF 154422001

SYMED LABS LTDPHENTERMINE HYDROCHLORIDE

DMF 248562011

ZYDUS LIFESCIENCES LTDPHENTERMINE HYDROCHLORIDE USP

DMF 261452012

MALLADI DRUGS AND PHARMACEUTICALS LTDPHENTERMINE HYDROCHLORIDE

DMF 386572023

TROPONWERKE GMBH CO KGInactivePHENTERMINE (C.A. NAME,-DIMETHYLPHENETHYLAMINE)

DMF 12141968

CAMBREX CHARLES CITY INCInactivePHENTERMINE HYDROCHLORIDE

DMF 154612001

CODY LABORATORIES INC A WHOLLY OWNED SUBSIDIARY OF LANNETT CO INCInactivePHENTERMINE HYDROCHLORIDE ACTIVE INGREDIENT

DMF 159402002

PISGAH LABS INCInactivePHENTERMINE HYDROCHLORIDE, USP

DMF 170392003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 15MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Dec 5, 2014

No patent or exclusivity listings for this strength.

#002 — 30MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 5, 2014